Vividion Archives -

Bayer’s quest to revamp its drug discovery engine continues apace, with the company’s recently acquired Vividion subsidiary forging

Bayer’s Vividion unit forges $930m cancer alliance with Tavros

https://pharmaphorum.com/news/bayers-vividion-unit-forges-930m-cancer-alliance-with-tavros/

Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will

Bayer bolsters R&D platform with $2bn Vividion takeover

https://pharmaphorum.com/news/bayer-bolsters-rd-platform-with-2bn-vividion-takeover/

Celgene has signed a deal with Vividion Therapeutics to develop drugs for oncology, inflammatory, and neurodegenerative diseases.

Celgene to tackle ‘undruggable’ targets with Vividion

https://pharmaphorum.com/news/celgene-to-tackle-undruggable-targets-with-vividion/

Vividion